Host Defense Peptides in Brief

1. Skarnes RC, Watson DWJBr. Antimicrobial factors of normal tissues and fluids. Bacteriol Rev 1957;21(4):273. SkarnesRC WatsonDWJBr Antimicrobial factors of normal tissues and fluids Bacteriol Rev 1957 21 4 273 Search in Google Scholar

2. Hirsch JGJTJoem. Phagocytin: a bactericidal substance from polymorphonuclear leucocytes. J Expt Med 1956;103(5):589. Hirsch JGJTJoem Phagocytin: a bactericidal substance from polymorphonuclear leucocytes J Expt Med 1956 103 5 589 Search in Google Scholar

3. Zeya H, Spitznagel JK. Cationic proteins of polymorphonuclear leukocyte lysosomes I. resolution of antibacterial and enzymatic activities. J Bacteriol 1966;91(2):750–4. ZeyaH SpitznagelJK Cationic proteins of polymorphonuclear leukocyte lysosomes I. resolution of antibacterial and enzymatic activities J Bacteriol 1966 91 2 750 4 Search in Google Scholar

4. Zeya H, Spitznagel JK. Cationic proteins of polymorphonuclear leukocyte lysosomes II. Composition, properties, and mechanism of antibacterial action. J Bacteriol 1966;91(2):755–62. ZeyaH SpitznagelJK Cationic proteins of polymorphonuclear leukocyte lysosomes II. Composition, properties, and mechanism of antibacterial action J Bacteriol 1966 91 2 755 62 Search in Google Scholar

5. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: Isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci USA 1988;23(2–3):360. ZasloffM Magainins, a class of antimicrobial peptides from Xenopus skin: Isolation, characterization of two active forms, and partial cDNA sequence of a precursor Proc Natl Acad Sci USA 1988 23 2–3 360 Search in Google Scholar

6. Riley MA, Gordon DM. The ecological role of bacteriocins in bacterial competition. Trends Microbiol 1999;7(3):129–33. RileyMA GordonDM The ecological role of bacteriocins in bacterial competition Trends Microbiol 1999 7 3 129 33 Search in Google Scholar

7. Brandenburg L-O, Merres J, Albrecht L-J, Varoga D, Pufe T. Antimicrobial peptides: multifunctional drugs for different applications. Polymers 2012;4(1):539–60. BrandenburgL-O MerresJ AlbrechtL-J VarogaD PufeT Antimicrobial peptides: multifunctional drugs for different applications Polymers 2012 4 1 539 60 Search in Google Scholar

8. De Smet K, Contreras R. Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol Lett 2005;27(18):1337–47. De SmetK ContrerasR Human antimicrobial peptides: defensins, cathelicidins and histatins Biotechnol Lett 2005 27 18 1337 47 Search in Google Scholar

9. Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 2003;55(1):27–55. YeamanMR YountNY Mechanisms of antimicrobial peptide action and resistance Pharmacol Rev 2003 55 1 27 55 Search in Google Scholar

10. Patrzykat A, Friedrich CL, Zhang L, Mendoza V, Hancock RE. Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob Agents Chemother 2002;46(3):605–14. PatrzykatA FriedrichCL ZhangL MendozaV HancockRE Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli Antimicrob Agents Chemother 2002 46 3 605 14 Search in Google Scholar

11. Krizsan A, Volke D, Weinert S, Sträter N, Knappe D, Hoffmann R. Insect-derived proline-rich antimicrobial peptides kill bacteria by inhibiting bacterial protein translation at the 70 S ribosome. Angew Chem Int Ed Engl 2014;53(45):12236–9. KrizsanA VolkeD WeinertS SträterN KnappeD HoffmannR Insect-derived proline-rich antimicrobial peptides kill bacteria by inhibiting bacterial protein translation at the 70 S ribosome Angew Chem Int Ed Engl 2014 53 45 12236 9 Search in Google Scholar

12. Ginsburg I. Bactericidal cationic peptides can also function as bacteriolysis-inducing agents mimicking beta-lactam antibiotics?; it is enigmatic why this concept is consistently disregarded. Med Hypotheses 2004;62(3):367–74. GinsburgI Bactericidal cationic peptides can also function as bacteriolysis-inducing agents mimicking beta-lactam antibiotics?; it is enigmatic why this concept is consistently disregarded Med Hypotheses 2004 62 3 367 74 Search in Google Scholar

13. Aboudy Y, Mendelson E, Shalit I, Bessalle R, Fridkin M. Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2. Int J Pept Protein Res 1994;43(6):573–82. AboudyY MendelsonE ShalitI BessalleR FridkinM Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2 Int J Pept Protein Res 1994 43 6 573 82 Search in Google Scholar

14. Belaid A, Aouni M, Khelifa R, Trabelsi A, Jemmali M, Hani K. In vitro antiviral activity of dermaseptins against herpes simplex virus type 1. J Med Virol 2002;66(2):229–34. BelaidA AouniM KhelifaR TrabelsiA JemmaliM HaniK In vitro antiviral activity of dermaseptins against herpes simplex virus type 1 J Med Virol 2002 66 2 229 34 Search in Google Scholar

15. Wachinger M, Kleinschmidt A, Winder D, von Pechmann N, Ludvigsen A, Neumann M, et al. Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. J Gen Virol 1998;79 (Pt 4):731–40. WachingerM KleinschmidtA WinderD von PechmannN LudvigsenA NeumannM Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression J Gen Virol 1998 79 Pt 4 731 40 Search in Google Scholar

16. Barlow PG, Svoboda P, Mackellar A, Nash AA, York IA, Pohl J, et al. Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin LL-37. PLOS ONE 2011;6(10):e25333. BarlowPG SvobodaP MackellarA NashAA YorkIA PohlJ Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin LL-37 PLOS ONE 2011 6 10 e25333 Search in Google Scholar

17. Buck CB, Day PM, Thompson CD, Lubkowski J, Lu W, Lowy DR, et al. Human alpha-defensins block papillomavirus infection. Proc Natl Acad Sci U S A 2006;103(5):1516–21. BuckCB DayPM ThompsonCD LubkowskiJ LuW LowyDR Human alpha-defensins block papillomavirus infection Proc Natl Acad Sci U S A 2006 103 5 1516 21 Search in Google Scholar

18. Daher KA, Selsted ME, Lehrer RI. Direct inactivation of viruses by human granulocyte defensins. J Virol 1986;60(3):1068–74. DaherKA SelstedME LehrerRI Direct inactivation of viruses by human granulocyte defensins J Virol 1986 60 3 1068 74 Search in Google Scholar

19. Sinha S, Cheshenko N, Lehrer RI, Herold BC. NP-1, a rabbit alpha-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2. Antimicrob Agents Chemother 2003;47(2):494–500. SinhaS CheshenkoN LehrerRI HeroldBC NP-1, a rabbit alpha-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2 Antimicrob Agents Chemother 2003 47 2 494 500 Search in Google Scholar

20. Chang TL, Vargas J, Jr., DelPortillo A, Klotman ME. Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity. J Clin Invest 2005;115(3):765–73. ChangTL VargasJJr. DelPortilloA KlotmanME Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity J Clin Invest 2005 115 3 765 73 Search in Google Scholar

21. Bergman P, Walter-Jallow L, Broliden K, Agerberth B, Söderlund J. The antimicrobial peptide LL-37 inhibits HIV-1 replication. Curr HIV Res 2007;5(4):410–5. BergmanP Walter-JallowL BrolidenK AgerberthB SöderlundJ The antimicrobial peptide LL-37 inhibits HIV-1 replication Curr HIV Res 2007 5 4 410 5 Search in Google Scholar

22. Liang QL, Zhou K, He HX. Retrocyclin 2: a new therapy against avian influenza H5N1 virus in vivo and vitro. Biotechnol Lett 2010;32(3):387–92. LiangQL ZhouK HeHX Retrocyclin 2: a new therapy against avian influenza H5N1 virus in vivo and vitro Biotechnol Lett 2010 32 3 387 92 Search in Google Scholar

23. Durnaś B, Wnorowska U, Pogoda K, Deptuła P, Wątek M, Piktel E, et al. Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites. PLOS ONE 2016;11(6):e0157242. DurnaśB WnorowskaU PogodaK DeptułaP WątekM PiktelE Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites PLOS ONE 2016 11 6 e0157242 Search in Google Scholar

24. De Lucca AJ, Bland JM, Jacks TJ, Grimm C, Walsh TJ. Fungicidal and binding properties of the natural peptides cecropin B and dermaseptin. Medical Mycology 1998;36(5):291–8. De LuccaAJ BlandJM JacksTJ GrimmC WalshTJ Fungicidal and binding properties of the natural peptides cecropin B and dermaseptin Medical Mycology 1998 36 5 291 8 Search in Google Scholar

25. Mangoni ML, Grovale N, Giorgi A, Mignogna G, Simmaco M, Barra D. Structure-function relationships in bombinins H, antimicrobial peptides from Bombina skin secretions. Peptides 2000;21(11):1673–9. MangoniML GrovaleN GiorgiA MignognaG SimmacoM BarraD Structure-function relationships in bombinins H, antimicrobial peptides from Bombina skin secretions Peptides 2000 21 11 1673 9 Search in Google Scholar

26. Mangoni ML, Marcellini HG, Simmaco M. Biological characterization and modes of action of temporins and bombinins H, multiple forms of short and mildly cationic anti-microbial peptides from amphibian skin. J Pept Sci 2007;13(9):603–13. MangoniML MarcelliniHG SimmacoM Biological characterization and modes of action of temporins and bombinins H, multiple forms of short and mildly cationic anti-microbial peptides from amphibian skin J Pept Sci 2007 13 9 603 13 Search in Google Scholar

27. Giacometti A, Cirioni O, Barchiesi F, Del Prete MS, Scalise G. Antimicrobial activity of polycationic peptides. Peptides 1999;20(11):1265–73. GiacomettiA CirioniO BarchiesiF Del PreteMS ScaliseG Antimicrobial activity of polycationic peptides Peptides 1999 20 11 1265 73 Search in Google Scholar

28. Schmatz DM, Romancheck MA, Pittarelli LA, Schwartz RE, Fromtling RA, Nollstadt KH, et al. Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors. Proceedings of the National Academy of Sciences of the United States of America 1990;87(15):5950–4. SchmatzDM RomancheckMA PittarelliLA SchwartzRE FromtlingRA NollstadtKH Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors Proceedings of the National Academy of Sciences of the United States of America 1990 87 15 5950 4 Search in Google Scholar

29. Kurtz MB, Douglas CM. Lipopeptide inhibitors of fungal glucan synthase. J Med Vet Mycol 1997;35(2):79–86. KurtzMB DouglasCM Lipopeptide inhibitors of fungal glucan synthase J Med Vet Mycol 1997 35 2 79 86 Search in Google Scholar

30. Hector RF, Zimmer BL, Pappagianis D. Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis. Antimicrob Agents Chemother 1990;34(4):587–93. HectorRF ZimmerBL PappagianisD Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis Antimicrob Agents Chemother 1990 34 4 587 93 Search in Google Scholar

31. Clemons KV, Stevens DA. Efficacy of nikkomycin Z against experimental pulmonary blastomycosis. Antimicrob Agents Chemother 1997;41(9):2026–8. ClemonsKV StevensDA Efficacy of nikkomycin Z against experimental pulmonary blastomycosis Antimicrob Agents Chemother 1997 41 9 2026 8 Search in Google Scholar

32. Nagiec MM, Nagiec EE, Baltisberger JA, Wells GB, Lester RL, Dickson RC. Sphingolipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene. J Biol Chem 1997;272(15):9809–17. NagiecMM NagiecEE BaltisbergerJA WellsGB LesterRL DicksonRC Sphingolipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene J Biol Chem 1997 272 15 9809 17 Search in Google Scholar

33. Takesako K, Kuroda H, Inoue T, Haruna F, Yoshikawa Y, Kato I, et al. Biological properties of aureobasidin A, a cyclic depsipeptide antifungal antibiotic. J Antibiot (Tokyo) 1993;46(9):1414–20. TakesakoK KurodaH InoueT HarunaF YoshikawaY KatoI Biological properties of aureobasidin A, a cyclic depsipeptide antifungal antibiotic J Antibiot (Tokyo) 1993 46 9 1414 20 Search in Google Scholar

34. Fehlbaum P, Bulet P, Michaut L, Lagueux M, Broekaert WF, Hetru C, et al. Insect immunity. Septic injury of Drosophila induces the synthesis of a potent antifungal peptide with sequence homology to plant antifungal peptides. J Biol Chem 1994;269(52):33159–63. FehlbaumP BuletP MichautL LagueuxM BroekaertWF HetruC Insect immunity. Septic injury of Drosophila induces the synthesis of a potent antifungal peptide with sequence homology to plant antifungal peptides J Biol Chem 1994 269 52 33159 63 Search in Google Scholar

35. Thevissen K, Kristensen HH, Thomma BP, Cammue BP, François IE. Therapeutic potential of antifungal plant and insect defensins. Drug Discov Today 2007;12(21–22):966–71. ThevissenK KristensenHH ThommaBP CammueBP FrançoisIE Therapeutic potential of antifungal plant and insect defensins Drug Discov Today 2007 12 21–22 966 71 Search in Google Scholar

36. Santarpia RP, 3rd, Pollock JJ, Renner RP, Gwinnett AJ. In vivo antifungal efficacy of salivary histidine-rich polypeptides: preliminary findings in a denture stomatitis model system. J Prosthet Dent 1991;66(5):693–9. SantarpiaRP3rd PollockJJ RennerRP GwinnettAJ In vivo antifungal efficacy of salivary histidine-rich polypeptides: preliminary findings in a denture stomatitis model system J Prosthet Dent 1991 66 5 693 9 Search in Google Scholar

37. Pollock JJ, Denepitiya L, MacKay BJ, Iacono VJ. Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans. Infect Immun 1984;44(3):702–7. PollockJJ DenepitiyaL MacKayBJ IaconoVJ Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans Infect Immun 1984 44 3 702 7 Search in Google Scholar

38. Rayhan R, Xu L, Santarpia RP, 3rd, Tylenda CA, Pollock JJ. Antifungal activities of salivary histidine-rich polypeptides against Candida albicans and other oral yeast isolates. Oral Microbiol Immunol 1992;7(1):51–2. RayhanR XuL SantarpiaRP3rd TylendaCA PollockJJ Antifungal activities of salivary histidine-rich polypeptides against Candida albicans and other oral yeast isolates Oral Microbiol Immunol 1992 7 1 51 2 Search in Google Scholar

39. Helmerhorst EJ, Reijnders IM, van't Hof W, Simoons-Smit I, Veerman EC, Amerongen AV. Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides. Antimicrob Agents Chemother 1999;43(3):702–4. HelmerhorstEJ ReijndersIM van't HofW Simoons-SmitI VeermanEC AmerongenAV Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides Antimicrob Agents Chemother 1999 43 3 702 4 Search in Google Scholar

40. Tsai H, Bobek LA. Human salivary histatin-5 exerts potent fungicidal activity against Cryptococcus neoformans. Biochim Biophys Acta 1997;1336(3):367–9. TsaiH BobekLA Human salivary histatin-5 exerts potent fungicidal activity against Cryptococcus neoformans Biochim Biophys Acta 1997 1336 3 367 9 Search in Google Scholar

41. Helmerhorst EJ, van't Hof W, Breeuwer P, Veerman EC, Abee T, Troxler RF, et al. Characterization of histatin 5 with respect to amphipathicity, hydrophobicity, and effects on cell and mitochondrial membrane integrity excludes a candidacidal mechanism of pore formation. J Biol Chem 2001;276(8):5643–9. HelmerhorstEJ van't HofW BreeuwerP VeermanEC AbeeT TroxlerRF Characterization of histatin 5 with respect to amphipathicity, hydrophobicity, and effects on cell and mitochondrial membrane integrity excludes a candidacidal mechanism of pore formation J Biol Chem 2001 276 8 5643 9 Search in Google Scholar

42. Gelhaus C, Jacobs T, Andrä J, Leippe M. The antimicrobial peptide NK-2, the core region of mammalian NK-lysin, kills intraerythrocytic Plasmodium falciparum. Antimicrob Agents Chemother 2008;52(5):1713–20. GelhausC JacobsT AndräJ LeippeM The antimicrobial peptide NK-2, the core region of mammalian NK-lysin, kills intraerythrocytic Plasmodium falciparum Antimicrob Agents Chemother 2008 52 5 1713 20 Search in Google Scholar

43. Jacobs T, Bruhn H, Gaworski I, Fleischer B, Leippe M. NK-Lysin and Its Shortened Analog NK-2 Exhibit Potent Activities against Trypanosoma cruzi. Antimicrob Agents Chemother 2003;47:607–13. JacobsT BruhnH GaworskiI FleischerB LeippeM NK-Lysin and Its Shortened Analog NK-2 Exhibit Potent Activities against Trypanosoma cruzi Antimicrob Agents Chemother 2003 47 607 13 Search in Google Scholar

44. Gwadz RW, Kaslow D, Lee JY, Maloy WL, Zasloff M, Miller LH. Effects of magainins and cecropins on the sporogonic development of malaria parasites in mosquitoes. Infect Immun 1989;57(9):2628–33. GwadzRW KaslowD LeeJY MaloyWL ZasloffM MillerLH Effects of magainins and cecropins on the sporogonic development of malaria parasites in mosquitoes Infect Immun 1989 57 9 2628 33 Search in Google Scholar

45. Aguilar-Diaz H, Canizalez-Roman A, Nepomuceno-Mejia T, Gallardo-Vera F, Hornelas-Orozco Y, Nazmi K, et al. Parasiticidal effect of synthetic bovine lactoferrin peptides on the enteric parasite Giardia intestinalis. Biochem Cell Biol 2017;95(1):82–90. Aguilar-DiazH Canizalez-RomanA Nepomuceno-MejiaT Gallardo-VeraF Hornelas-OrozcoY NazmiK Parasiticidal effect of synthetic bovine lactoferrin peptides on the enteric parasite Giardia intestinalis Biochem Cell Biol 2017 95 1 82 90 Search in Google Scholar

46. Ericksen B, Wu Z, Lu W, Lehrer RI. Antibacterial activity and specificity of the six human {alpha}-defensins. Antimicrob Agents Chemother 2005;49(1):269–75. EricksenB WuZ LuW LehrerRI Antibacterial activity and specificity of the six human {alpha}-defensins Antimicrob Agents Chemother 2005 49 1 269 75 Search in Google Scholar

47. Ellison RT, 3rd, Giehl TJ. Killing of gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest 1991;88(4):1080–91. EllisonRT3rd GiehlTJ Killing of gram-negative bacteria by lactoferrin and lysozyme J Clin Invest 1991 88 4 1080 91 Search in Google Scholar

48. Guo Y, Xun M, Han J. A bovine myeloid antimicrobial peptide (BMAP-28) and its analogs kill pan-drug-resistant Acinetobacter baumannii by interacting with outer membrane protein A (OmpA). Medicine (Baltimore) 2018;97(42):e12832. GuoY XunM HanJ A bovine myeloid antimicrobial peptide (BMAP-28) and its analogs kill pan-drug-resistant Acinetobacter baumannii by interacting with outer membrane protein A (OmpA) Medicine (Baltimore) 2018 97 42 e12832 Search in Google Scholar

49. Poirel L, Jayol A, Nordmann P. Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes. Clin Microbiol Rev 2017;30(2):557–96. PoirelL JayolA NordmannP Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes Clin Microbiol Rev 2017 30 2 557 96 Search in Google Scholar

50. Beringer PM, Bensman TJ, Ho H, Agnello M, Denovel N, Nguyen A, et al. Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa. J Antimicrob Chemother 2016;71(1):181–8. BeringerPM BensmanTJ HoH AgnelloM DenovelN NguyenA Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa J Antimicrob Chemother 2016 71 1 181 8 Search in Google Scholar

51. Brötz H, Bierbaum G, Leopold K, Reynolds PE, Sahl HG. The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II. Antimicrob Agents Chemother 1998;42(1):154–60. BrötzH BierbaumG LeopoldK ReynoldsPE SahlHG The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II Antimicrob Agents Chemother 1998 42 1 154 60 Search in Google Scholar

52. Chitnis SN, Prasad KS. Seminalplasmin, an antimicrobial protein from bovine seminal plasma, inhibits peptidoglycan synthesis in Escherichia coli. FEMS Microbiol Lett 1990;60(3):281–4. ChitnisSN PrasadKS Seminalplasmin, an antimicrobial protein from bovine seminal plasma, inhibits peptidoglycan synthesis in Escherichia coli FEMS Microbiol Lett 1990 60 3 281 4 Search in Google Scholar

53. Furci L, Baldan R, Bianchini V, Trovato A, Ossi C, Cichero P, et al. New role for human α-defensin 5 in the fight against hypervirulent Clostridium difficile strains. Infect Immun 2015;83(3):986–95. FurciL BaldanR BianchiniV TrovatoA OssiC CicheroP New role for human α-defensin 5 in the fight against hypervirulent Clostridium difficile strains Infect Immun 2015 83 3 986 95 Search in Google Scholar

54. Maisetta G, Batoni G, Esin S, Florio W, Bottai D, Favilli F, et al. In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains. Antimicrob Agents Chemother 2006;50(2):806–9. MaisettaG BatoniG EsinS FlorioW BottaiD FavilliF In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains Antimicrob Agents Chemother 2006 50 2 806 9 Search in Google Scholar

55. Xiong YQ, Bayer AS, Yeaman MR. Inhibition of intracellular macromolecular synthesis in Staphylococcus aureus by thrombin-induced platelet microbicidal proteins. J Infect Dis 2002;185(3):348–56. XiongYQ BayerAS YeamanMR Inhibition of intracellular macromolecular synthesis in Staphylococcus aureus by thrombin-induced platelet microbicidal proteins J Infect Dis 2002 185 3 348 56 Search in Google Scholar

56. Wilmes M, Stockem M, Bierbaum G, Schlag M, Götz F, Tran DQ, et al. Killing of staphylococci by θ-defensins involves membrane impairment and activation of autolytic enzymes. Antibiotics (Basel) 2014;3(4):617–31. WilmesM StockemM BierbaumG SchlagM GötzF TranDQ Killing of staphylococci by θ-defensins involves membrane impairment and activation of autolytic enzymes Antibiotics (Basel) 2014 3 4 617 31 Search in Google Scholar

57. Furci L, Tolazzi M, Sironi F, Vassena L, Lusso P. Inhibition of HIV-1 infection by human α-defensin-5, a natural antimicrobial peptide expressed in the genital and intestinal mucosae. PLoS One 2012;7(9):e45208. FurciL TolazziM SironiF VassenaL LussoP Inhibition of HIV-1 infection by human α-defensin-5, a natural antimicrobial peptide expressed in the genital and intestinal mucosae PLoS One 2012 7 9 e45208 Search in Google Scholar

58. Quiñones-Mateu ME, Lederman MM, Feng Z, Chakraborty B, Weber J, Rangel HR, et al. Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. Aids 2003;17(16):F39–48. Quiñones-MateuME LedermanMM FengZ ChakrabortyB WeberJ RangelHR Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication Aids 2003 17 16 F39 48 Search in Google Scholar

59. Seidel A, Ye Y, de Armas LR, Soto M, Yarosh W, Marcsisin RA, et al. Cyclic and acyclic defensins inhibit human immunodeficiency virus type-1 replication by different mechanisms. PLoS One 2010;5(3):e9737. SeidelA YeY de ArmasLR SotoM YaroshW MarcsisinRA Cyclic and acyclic defensins inhibit human immunodeficiency virus type-1 replication by different mechanisms PLoS One 2010 5 3 e9737 Search in Google Scholar

60. Hazrati E, Galen B, Lu W, Wang W, Ouyang Y, Keller MJ, et al. Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection. J Immunol 2006;177(12):8658–66. HazratiE GalenB LuW WangW OuyangY KellerMJ Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection J Immunol 2006 177 12 8658 66 Search in Google Scholar

61. Endo M, Takesako K, Kato I, Yamaguchi H. Fungicidal action of aureobasidin A, a cyclic depsipeptide antifungal antibiotic, against Saccharomyces cerevisiae. Antimicrob Agents Chemother 1997;41(3):672–6. EndoM TakesakoK KatoI YamaguchiH Fungicidal action of aureobasidin A, a cyclic depsipeptide antifungal antibiotic, against Saccharomyces cerevisiae Antimicrob Agents Chemother 1997 41 3 672 6 Search in Google Scholar

62. Aerts AM, François IE, Meert EM, Li QT, Cammue BP, Thevissen K. The antifungal activity of RsAFP2, a plant defensin from raphanus sativus, involves the induction of reactive oxygen species in Candida albicans. J Mol Microbiol Biotechnol 2007;13(4):243–7. AertsAM FrançoisIE MeertEM LiQT CammueBP ThevissenK The antifungal activity of RsAFP2, a plant defensin from raphanus sativus, involves the induction of reactive oxygen species in Candida albicans J Mol Microbiol Biotechnol 2007 13 4 243 7 Search in Google Scholar

63. Aerts AM, Bammens L, Govaert G, Carmona-Gutierrez D, Madeo F, Cammue BP, et al. The Antifungal Plant Defensin HsAFP1 from Heuchera sanguinea Induces Apoptosis in Candida albicans. Front Microbiol. 2011;2:47. AertsAM BammensL GovaertG Carmona-GutierrezD MadeoF CammueBP The Antifungal Plant Defensin HsAFP1 from Heuchera sanguinea Induces Apoptosis in Candida albicans Front Microbiol. 2011 2 47 Search in Google Scholar

64. Aerts AM, François IE, Bammens L, Cammue BP, Smets B, Winderickx J, et al. Level of M(IP)2C sphingolipid affects plant defensin sensitivity, oxidative stress resistance and chronological life-span in yeast. FEBS Lett 2006;580(7):1903–7. AertsAM FrançoisIE BammensL CammueBP SmetsB WinderickxJ Level of M(IP)2C sphingolipid affects plant defensin sensitivity, oxidative stress resistance and chronological life-span in yeast FEBS Lett 2006 580 7 1903 7 Search in Google Scholar

65. Thevissen K, Ghazi A, De Samblanx GW, Brownlee C, Osborn RW, Broekaert WF. Fungal membrane responses induced by plant defensins and thionins. J Biol Chem 1996;271(25):15018–25. ThevissenK GhaziA De SamblanxGW BrownleeC OsbornRW BroekaertWF Fungal membrane responses induced by plant defensins and thionins J Biol Chem 1996 271 25 15018 25 Search in Google Scholar

66. Lobo DS, Pereira IB, Fragel-Madeira L, Medeiros LN, Cabral LM, Faria J, et al. Antifungal Pisum sativum defensin 1 interacts with Neurospora crassa cyclin F related to the cell cycle. Biochemistry 2007;46(4):987–96. LoboDS PereiraIB Fragel-MadeiraL MedeirosLN CabralLM FariaJ Antifungal Pisum sativum defensin 1 interacts with Neurospora crassa cyclin F related to the cell cycle Biochemistry 2007 46 4 987 96 Search in Google Scholar

67. Hancock RE, Diamond G. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol 2000;8(9):402–10. HancockRE DiamondG The role of cationic antimicrobial peptides in innate host defences Trends Microbiol 2000 8 9 402 10 Search in Google Scholar

68. Beisswenger C, Bals R. Functions of antimicrobial peptides in host defense and immunity. Curr Protein Pept Sci 2005;6(3):255–64. BeisswengerC BalsR Functions of antimicrobial peptides in host defense and immunity Curr Protein Pept Sci 2005 6 3 255 64 Search in Google Scholar

69. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol. 2004;75(1):39–48. ZanettiM Cathelicidins, multifunctional peptides of the innate immunity J Leukoc Biol. 2004 75 1 39 48 Search in Google Scholar

70. Sørensen OE, Cowland JB, Theilgaard-Mönch K, Liu L, Ganz T, Borregaard N. Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 2003;170(11):5583–9. SørensenOE CowlandJB Theilgaard-MönchK LiuL GanzT BorregaardN Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors J Immunol 2003 170 11 5583 9 Search in Google Scholar

71. Yang B, Suwanpradid J, Sanchez-Lagunes R, Choi HW, Hoang P, Wang D, et al. IL-27 Facilitates Skin Wound Healing through Induction of Epidermal Proliferation and Host Defense. J Invest Dermatol. 2017;137(5):1166–75. YangB SuwanpradidJ Sanchez-LagunesR ChoiHW HoangP WangD IL-27 Facilitates Skin Wound Healing through Induction of Epidermal Proliferation and Host Defense J Invest Dermatol. 2017 137 5 1166 75 Search in Google Scholar

72. Grigat J, Soruri A, Forssmann U, Riggert J, Zwirner J. Chemoattraction of Macrophages, T Lymphocytes, and Mast Cells Is Evolutionarily Conserved within the Human α-Defensin Family. J Immunol 2007;179(6):3958–65. GrigatJ SoruriA ForssmannU RiggertJ ZwirnerJ Chemoattraction of Macrophages, T Lymphocytes, and Mast Cells Is Evolutionarily Conserved within the Human α-Defensin Family J Immunol 2007 179 6 3958 65 Search in Google Scholar

73. Toyoguchi T, Ebihara M, Ojima F, Hosoya J, Shoji T, Nakagawa Y. Histamine release induced by antimicrobial agents and effects of antimicrobial agents on vancomycin-induced histamine release from rat peritoneal mast cells. J Pharm Pharmacol 2000;52(3):327–31. ToyoguchiT EbiharaM OjimaF HosoyaJ ShojiT NakagawaY Histamine release induced by antimicrobial agents and effects of antimicrobial agents on vancomycin-induced histamine release from rat peritoneal mast cells J Pharm Pharmacol 2000 52 3 327 31 Search in Google Scholar

74. Befus AD, Mowat C, Gilchrist M, Hu J, Solomon S, Bateman A. Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action. J Immunol 1999;163(2):947–53. BefusAD MowatC GilchristM HuJ SolomonS BatemanA Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action J Immunol 1999 163 2 947 53 Search in Google Scholar

75. Zughaier SM, Shafer WM, Stephens DS. Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages. Cell Microbiol 2005;7(9):1251–62. ZughaierSM ShaferWM StephensDS Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages Cell Microbiol 2005 7 9 1251 62 Search in Google Scholar

76. Ammar B, Périanin A, Mor A, Sarfati G, Tissot M, Nicolas P, et al. Dermaseptin, a peptide antibiotic, stimulates microbicidal activities of polymorphonuclear leukocytes. Biochem Biophys Res Commun 1998;247(3):870–5. AmmarB PérianinA MorA SarfatiG TissotM NicolasP Dermaseptin, a peptide antibiotic, stimulates microbicidal activities of polymorphonuclear leukocytes Biochem Biophys Res Commun 1998 247 3 870 5 Search in Google Scholar

77. Xie H, Wei J, Qin Q. Antiviral function of Tachyplesin I against iridovirus and nodavirus. Fish Shellfish Immunol 2016;58:96–102. XieH WeiJ QinQ Antiviral function of Tachyplesin I against iridovirus and nodavirus Fish Shellfish Immunol 2016 58 96 102 Search in Google Scholar

78. Lillard J, Boyaka P, Chertov O, Oppenheim J, McGhee J. Mechanisms for induction of aquired host immunity by neutrophil peptide defensins. Proceedings of the National Academy of Sciences of the United States of America 1999;96:651–6. LillardJ BoyakaP ChertovO OppenheimJ McGheeJ Mechanisms for induction of aquired host immunity by neutrophil peptide defensins Proceedings of the National Academy of Sciences of the United States of America 1999 96 651 6 Search in Google Scholar

79. Hancock RE, Scott MG. The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci U S A 2000;97(16):8856–61. HancockRE ScottMG The role of antimicrobial peptides in animal defenses Proc Natl Acad Sci U S A 2000 97 16 8856 61 Search in Google Scholar

80. Giuliani A, Pirri G, Rinaldi AC. Antimicrobial peptides: the LPS connection. Methods Mol Biol 2010;618:137–54. GiulianiA PirriG RinaldiAC Antimicrobial peptides: the LPS connection Methods Mol Biol 2010 618 137 54 Search in Google Scholar

81. Scott MG, Davidson DJ, Gold MR, Bowdish D, Hancock RE. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol 2002;169(7):3883–91. ScottMG DavidsonDJ GoldMR BowdishD HancockRE The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses J Immunol 2002 169 7 3883 91 Search in Google Scholar

82. Popovic S, Djurdjevic P, Zaric M, Mijailovic Z, Avramovic D, Baskic DJPb. Effects of host defense peptides B2RP, Brevinin-2GU, D-Lys-Temporin, Lys-XT-7 and D-Lys-Ascaphin-8 on peripheral blood mononuclear cells: Preliminary study. Periodicum Biologorum 2017;119(2). PopovicS DjurdjevicP ZaricM MijailovicZ AvramovicD BaskicDJPb Effects of host defense peptides B2RP, Brevinin-2GU, D-Lys-Temporin, Lys-XT-7 and D-Lys-Ascaphin-8 on peripheral blood mononuclear cells: Preliminary study Periodicum Biologorum 2017 119 2 Search in Google Scholar

83. Mookherjee N, Brown KL, Bowdish DM, Doria S, Falsafi R, Hokamp K, et al. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol 2006;176(4):2455–64. MookherjeeN BrownKL BowdishDM DoriaS FalsafiR HokampK Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37 J Immunol 2006 176 4 2455 64 Search in Google Scholar

84. Davidson DJ, Currie AJ, Reid GS, Bowdish DM, MacDonald KL, Ma RC, et al. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol 2004;172(2):1146–56. DavidsonDJ CurrieAJ ReidGS BowdishDM MacDonaldKL MaRC The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization J Immunol 2004 172 2 1146 56 Search in Google Scholar

85. Kandler K, Shaykhiev R, Kleemann P, Klescz F, Lohoff M, Vogelmeier C, et al. The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands. Int Immunol 2006;18(12):1729–36. KandlerK ShaykhievR KleemannP KlesczF LohoffM VogelmeierC The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands Int Immunol 2006 18 12 1729 36 Search in Google Scholar

86. Brogden KA, Heidari M, Sacco RE, Palmquist D, Guthmiller JM, Johnson GK, et al. Defensin-induced adaptive immunity in mice and its potential in preventing periodontal disease. Oral Microbiol Immunol 2003;18(2):95–9. BrogdenKA HeidariM SaccoRE PalmquistD GuthmillerJM JohnsonGK Defensin-induced adaptive immunity in mice and its potential in preventing periodontal disease Oral Microbiol Immunol 2003 18 2 95 9 Search in Google Scholar

87. Tani K, Murphy WJ, Chertov O, Salcedo R, Koh CY, Utsunomiya I, et al. Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens. Int Immunol 2000;12(5):691–700. TaniK MurphyWJ ChertovO SalcedoR KohCY UtsunomiyaI Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens Int Immunol 2000 12 5 691 700 Search in Google Scholar

88. Mader JS, Hoskin DW. Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opin Investig Drugs 2006;15(8):933–46. MaderJS HoskinDW Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment Expert Opin Investig Drugs 2006 15 8 933 46 Search in Google Scholar

89. Risso A, Zanetti M, Gennaro R. Cytotoxicity and apoptosis mediated by two peptides of innate immunity. Cell Immunol 1998;189(2):107–15. RissoA ZanettiM GennaroR Cytotoxicity and apoptosis mediated by two peptides of innate immunity Cell Immunol 1998 189 2 107 15 Search in Google Scholar

90. Ye JS, Zheng XJ, Leung KW, Chen HM, Sheu FS. Induction of transient ion channel-like pores in a cancer cell by antibiotic peptide. J Biochem 2004;136(2):255–9. YeJS ZhengXJ LeungKW ChenHM SheuFS Induction of transient ion channel-like pores in a cancer cell by antibiotic peptide J Biochem 2004 136 2 255 9 Search in Google Scholar

91. Chen HM, Wang W, Smith D, Chan SC. Effects of the anti-bacterial peptide cecropin B and its analogs, cecropins B-1 and B-2, on liposomes, bacteria, and cancer cells. Biochim Biophys Acta 1997;1336(2):171–9. ChenHM WangW SmithD ChanSC Effects of the anti-bacterial peptide cecropin B and its analogs, cecropins B-1 and B-2, on liposomes, bacteria, and cancer cells Biochim Biophys Acta 1997 1336 2 171 9 Search in Google Scholar

92. Okumura K, Itoh A, Isogai E, Hirose K, Hosokawa Y, Abiko Y, et al. C-terminal domain of human CAP18 antimicrobial peptide induces apoptosis in oral squamous cell carcinoma SAS-H1 cells. Cancer Lett 2004;212(2):185–94. OkumuraK ItohA IsogaiE HiroseK HosokawaY AbikoY C-terminal domain of human CAP18 antimicrobial peptide induces apoptosis in oral squamous cell carcinoma SAS-H1 cells Cancer Lett 2004 212 2 185 94 Search in Google Scholar

93. Doyle J, Brinkworth CS, Wegener KL, Carver JA, Llewellyn LE, Olver IN, et al. nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications. The solution structure of a modified citropin 1.1. Eur J Biochem 2003;270(6):1141–53. DoyleJ BrinkworthCS WegenerKL CarverJA LlewellynLE OlverIN nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modification. The solution structure of a modified citropin 1.1 Eur J Biochem 2003 270 6 1141 53 Search in Google Scholar

94. Kim S, Kim SS, Bang YJ, Kim SJ, Lee BJ. In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines. Peptides 2003;24(7):945–53. KimS KimSS BangYJ KimSJ LeeBJ In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines Peptides 2003 24 7 945 53 Search in Google Scholar

95. Lehmann J, Retz M, Sidhu SS, Suttmann H, Sell M, Paulsen F, et al. Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines. Eur Urol 2006;50(1):141–7. LehmannJ RetzM SidhuSS SuttmannH SellM PaulsenF Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines Eur Urol 2006 50 1 141 7 Search in Google Scholar

96. Chen YQ, Min C, Sang M, Han YY, Ma X, Xue XQ, et al. A cationic amphiphilic peptide ABP-CM4 exhibits selective cytotoxicity against leukemia cells. Peptides 2010;31(8):1504–10. ChenYQ MinC SangM HanYY MaX XueXQ A cationic amphiphilic peptide ABP-CM4 exhibits selective cytotoxicity against leukemia cells Peptides 2010 31 8 1504 10 Search in Google Scholar

97. Riedl S, Rinner B, Asslaber M, Schaider H, Walzer S, Novak A, et al. In search of a novel target - phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy. Biochim Biophys Acta 2011;1808(11):2638–45. RiedlS RinnerB AsslaberM SchaiderH WalzerS NovakA In search of a novel target - phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy Biochim Biophys Acta 2011 1808 11 2638 45 Search in Google Scholar

98. Zachowski A. Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement. Biochem J 1993;294 (Pt 1)(Pt 1):1–14. ZachowskiA Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement Biochem J 1993 294 (Pt 1) Pt 1 1 14 Search in Google Scholar

99. Risso A, Braidot E, Sordano MC, Vianello A, Macrì F, Skerlavaj B, et al. BMAP-28, an antibiotic peptide of innate immunity, induces cell death through opening of the mitochondrial permeability transition pore. Mol Cell Biol 2002;22(6):1926–35. RissoA BraidotE SordanoMC VianelloA MacrìF SkerlavajB BMAP-28, an antibiotic peptide of innate immunity, induces cell death through opening of the mitochondrial permeability transition pore Mol Cell Biol 2002 22 6 1926 35 Search in Google Scholar

100. Berge G, Eliassen LT, Camilio KA, Bartnes K, Sveinbjørnsson B, Rekdal O. Therapeutic vaccination against a murine lymphoma by intratumoral injection of a cationic anticancer peptide. Cancer Immunol Immunother 2010;59(8):1285–94. BergeG EliassenLT CamilioKA BartnesK SveinbjørnssonB RekdalO Therapeutic vaccination against a murine lymphoma by intratumoral injection of a cationic anticancer peptide Cancer Immunol Immunother 2010 59 8 1285 94 Search in Google Scholar

101. Oršolić N, Josipović P, Bašić IJEJoNT. Direct antitumor activity of honey bee venom in vivo and in vitro. Egyptian Journal of Natural Toxins 2009;6(1):1–15. OršolićN JosipovićP BašićIJEJoNT Direct antitumor activity of honey bee venom in vivo and in vitro Egyptian Journal of Natural Toxins 2009 6 1 1 15 Search in Google Scholar

102. Wu SP, Huang TC, Lin CC, Hui CF, Lin CH, Chen JY. Pardaxin, a fish antimicrobial peptide, exhibits antitumor activity toward murine fibrosarcoma in vitro and in vivo. Mar Drugs 2012;10(8):1852–72. WuSP HuangTC LinCC HuiCF LinCH ChenJY Pardaxin, a fish antimicrobial peptide, exhibits antitumor activity toward murine fibrosarcoma in vitro and in vivo Mar Drugs 2012 10 8 1852 72 Search in Google Scholar

103. Azevedo RA, Ferreira AK, Auada AVV, Pasqualoto KFM, Marques-Porto R, Maria DA, et al. Antitumor effect of cationic INKKI peptide from bovine β-casein on melanoma B16F10. J Canc Ther 2012. AzevedoRA FerreiraAK AuadaAVV PasqualotoKFM Marques-PortoR MariaDA Antitumor effect of cationic INKKI peptide from bovine β-casein on melanoma B16F10 J Canc Ther 2012 Search in Google Scholar

104. Chen YL, Li JH, Yu CY, Lin CJ, Chiu PH, Chen PW, et al. Novel cationic antimicrobial peptide GW-H1 induced caspase-dependent apoptosis of hepatocellular carcinoma cell lines. Peptides 2012;36(2):257–65. ChenYL LiJH YuCY LinCJ ChiuPH ChenPW Novel cationic antimicrobial peptide GW-H1 induced caspase-dependent apoptosis of hepatocellular carcinoma cell lines Peptides 2012 36 2 257 65 Search in Google Scholar

105. Rodrigues EG, Dobroff AS, Cavarsan CF, Paschoalin T, Nimrichter L, Mortara RA, et al. Effective topical treatment of subcutaneous murine B16F10-Nex2 melanoma by the antimicrobial peptide gomesin. Neoplasia 2008;10(1):61–8. RodriguesEG DobroffAS CavarsanCF PaschoalinT NimrichterL MortaraRA Effective topical treatment of subcutaneous murine B16F10-Nex2 melanoma by the antimicrobial peptide gomesin Neoplasia 2008 10 1 61 8 Search in Google Scholar

106. Hilchie AL, Doucette CD, Pinto DM, Patrzykat A, Douglas S, Hoskin DW. Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts. Breast Cancer Res 2011;13(5):R102. HilchieAL DoucetteCD PintoDM PatrzykatA DouglasS HoskinDW Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts Breast Cancer Res 2011 13 5 R102 Search in Google Scholar

107. Liu S, Yang H, Wan L, Cai HW, Li SF, Li YP, et al. Enhancement of cytotoxicity of antimicrobial peptide magainin II in tumor cells by bombesin-targeted delivery. Acta Pharmacol Sin 2011;32(1):79–88. LiuS YangH WanL CaiHW LiSF LiYP Enhancement of cytotoxicity of antimicrobial peptide magainin II in tumor cells by bombesin-targeted delivery Acta Pharmacol Sin 2011 32 1 79 88 Search in Google Scholar

108. Winder D, Günzburg WH, Erfle V, Salmons B. Expression of antimicrobial peptides has an antitumour effect in human cells. Biochem Biophys Res Commun 1998;242(3):608–12. WinderD GünzburgWH ErfleV SalmonsB Expression of antimicrobial peptides has an antitumour effect in human cells Biochem Biophys Res Commun 1998 242 3 608 12 Search in Google Scholar

109. Russell PJ, Hewish D, Carter T, Sterling-Levis K, Ow K, Hattarki M, et al. Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies. Cancer Immunol Immunother 2004;53(5):411–21. RussellPJ HewishD CarterT Sterling-LevisK OwK HattarkiM Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies Cancer Immunol Immunother 2004 53 5 411 21 Search in Google Scholar

110. Hui L, Leung K, Chen HM. The combined effects of antibacterial peptide cecropin A and anti-cancer agents on leukemia cells. Anticancer Res 2002;22(5):2811–6. HuiL LeungK ChenHM The combined effects of antibacterial peptide cecropin A and anti-cancer agents on leukemia cells Anticancer Res 2002 22 5 2811 6 Search in Google Scholar

111. Johnstone SA, Gelmon K, Mayer LD, Hancock RE, Bally MB. In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptidemediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines. Anticancer Drug Des 2000;15(2):151–60. JohnstoneSA GelmonK MayerLD HancockRE BallyMB In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptidemediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines Anticancer Drug Des 2000 15 2 151 60 Search in Google Scholar

112. Piotrowska U, Sobczak M, Oledzka E. Current state of a dual behaviour of antimicrobial peptides-Therapeutic agents and promising delivery vectors. Chem Biol Drug Des 2017;90(6):1079–93. PiotrowskaU SobczakM OledzkaE Current state of a dual behaviour of antimicrobial peptides-Therapeutic agents and promising delivery vectors Chem Biol Drug Des 2017 90 6 1079 93 Search in Google Scholar

113. Fjell CD, Hiss JA, Hancock RE, Schneider G. Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov 2011;11(1):37–51. FjellCD HissJA HancockRE SchneiderG Designing antimicrobial peptides: form follows function Nat Rev Drug Discov 2011 11 1 37 51 Search in Google Scholar

114. Meiller TF, Hube B, Schild L, Shirtliff ME, Scheper MA, Winkler R, et al. A novel immune evasion strategy of candida albicans: proteolytic cleavage of a salivary antimicrobial peptide. PLoS One 2009;4(4):e5039. MeillerTF HubeB SchildL ShirtliffME ScheperMA WinklerR A novel immune evasion strategy of candida albicans: proteolytic cleavage of a salivary antimicrobial peptide PLoS One 2009 4 4 e5039 Search in Google Scholar

115. Roy H, Dare K, Ibba M. Adaptation of the bacterial membrane to changing environments using aminoacylated phospholipids. Mol Microbiol 2009;71(3):547–50. RoyH DareK IbbaM Adaptation of the bacterial membrane to changing environments using aminoacylated phospholipids Mol Microbiol 2009 71 3 547 50 Search in Google Scholar

116. Giménez D, Andreu C, del Olmo M, Varea T, Diaz D, Asensio G. The introduction of fluorine atoms or trifluoromethyl groups in short cationic peptides enhances their antimicrobial activity. Bioorg Med Chem 2006;14(20):6971–8. GiménezD AndreuC del OlmoM VareaT DiazD AsensioG The introduction of fluorine atoms or trifluoromethyl groups in short cationic peptides enhances their antimicrobial activity Bioorg Med Chem 2006 14 20 6971 8 Search in Google Scholar

117. Papo N, Shai Y. New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells. Biochemistry 2003;42(31):9346–54. PapoN ShaiY New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells Biochemistry 2003 42 31 9346 54 Search in Google Scholar

118. Svenson J, Stensen W, Brandsdal BO, Haug BE, Monrad J, Svendsen JS. Antimicrobial peptides with stability toward tryptic degradation. Biochemistry 2008;47(12):3777–88. SvensonJ StensenW BrandsdalBO HaugBE MonradJ SvendsenJS Antimicrobial peptides with stability toward tryptic degradation Biochemistry 2008 47 12 3777 88 Search in Google Scholar

119. Knappe D, Henklein P, Hoffmann R, Hilpert K. Easy strategy to protect antimicrobial peptides from fast degradation in serum. Antimicrob Agents Chemother 2010;54(9):4003–5. KnappeD HenkleinP HoffmannR HilpertK Easy strategy to protect antimicrobial peptides from fast degradation in serum Antimicrob Agents Chemother 2010 54 9 4003 5 Search in Google Scholar

120. Arias M, Hilchie AL, Haney EF, Bolscher JG, Hyndman ME, Hancock RE, et al. Anticancer activities of bovine and human lactoferricin-derived peptides. Biochem Cell Biol 2017;95(1):91–8. AriasM HilchieAL HaneyEF BolscherJG HyndmanME HancockRE Anticancer activities of bovine and human lactoferricin-derived peptides Biochem Cell Biol 2017 95 1 91 8 Search in Google Scholar

121. Ghosh C, Manjunath GB, Akkapeddi P, Yarlagadda V, Hoque J, Uppu DS, et al. Small molecular antibacterial peptoid mimics: the simpler the better! J Med Chem 2014;57(4):1428–36. GhoshC ManjunathGB AkkapeddiP YarlagaddaV HoqueJ UppuDS Small molecular antibacterial peptoid mimics: the simpler the better! J Med Chem 2014 57 4 1428 36 Search in Google Scholar

122. Wang Y, Yang YJ, Chen YN, Zhao HY, Zhang S. Computer-aided design, structural dynamics analysis, and in vitro susceptibility test of antibacterial peptides incorporating unnatural amino acids against microbial infections. Comput Methods Programs Biomed 2016;134:215–23. WangY YangYJ ChenYN ZhaoHY ZhangS Computer-aided design, structural dynamics analysis, and in vitro susceptibility test of antibacterial peptides incorporating unnatural amino acids against microbial infections Comput Methods Programs Biomed 2016 134 215 23 Search in Google Scholar

123. de la Fuente-Núñez C, Reffuveille F, Haney EF, Straus SK, Hancock RE. Broad-spectrum anti-biofilm peptide that targets a cellular stress response. PLoS Pathog 2014;10(5):e1004152. de la Fuente-NúñezC ReffuveilleF HaneyEF StrausSK HancockRE Broad-spectrum anti-biofilm peptide that targets a cellular stress response PLoS Pathog 2014 10 5 e1004152 Search in Google Scholar

124. Lohan S, Cameotra SS, Bisht GS. Systematic study of non-natural short cationic lipopeptides as novel broad-spectrum antimicrobial agents. Chem Biol Drug Des 2013;82(5):557–66. LohanS CameotraSS BishtGS Systematic study of non-natural short cationic lipopeptides as novel broad-spectrum antimicrobial agents Chem Biol Drug Des 2013 82 5 557 66 Search in Google Scholar

125. de Breij A, Riool M, Kwakman PH, de Boer L, Cordfunke RA, Drijfhout JW, et al. Prevention of Staphylococcus aureus biomaterial-associated infections using a polymer-lipid coating containing the antimicrobial peptide OP-145. J Control Release 2016;222:1–8. de BreijA RioolM KwakmanPH de BoerL CordfunkeRA DrijfhoutJW Prevention of Staphylococcus aureus biomaterial-associated infections using a polymer-lipid coating containing the antimicrobial peptide OP-145 J Control Release 2016 222 1 8 Search in Google Scholar

126. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med 2003;348(12):1123–33. McGeeDC GouldMK Preventing complications of central venous catheterization N Engl J Med 2003 348 12 1123 33 Search in Google Scholar

127. Rijsbergen M, Rijneveld R, Todd M, Feiss GL, Kouwenhoven STP, Quint KD, et al. Results of phase 2 trials exploring the safety and efficacy of omiganan in patients with human papillomavirus-induced genital lesions. Br J Clin Pharmacol 2020;86(11):2133–43. RijsbergenM RijneveldR ToddM FeissGL KouwenhovenSTP QuintKD Results of phase 2 trials exploring the safety and efficacy of omiganan in patients with human papillomavirus-induced genital lesions Br J Clin Pharmacol 2020 86 11 2133 43 Search in Google Scholar

128. Lipsky BA, Holroyd KJ, Zasloff M. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Clin Infect Dis 2008;47(12):1537–45. LipskyBA HolroydKJ ZasloffM Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream Clin Infect Dis 2008 47 12 1537 45 Search in Google Scholar

129. Cheng KT, Wu CL, Yip BS, Chih YH, Peng KL, Hsu SY, et al. The Interactions between the Antimicrobial Peptide P-113 and Living Candida albicans Cells Shed Light on Mechanisms of Antifungal Activity and Resistance. Int J Mol Sci 2020;21(7). ChengKT WuCL YipBS ChihYH PengKL HsuSY The Interactions between the Antimicrobial Peptide P-113 and Living Candida albicans Cells Shed Light on Mechanisms of Antifungal Activity and Resistance Int J Mol Sci 2020 21 7 Search in Google Scholar

130. van der Does AM, Bogaards SJ, Ravensbergen B, Beekhuizen H, van Dissel JT, Nibbering PH. Antimicrobial peptide hLF1-11 directs granulocyte-macrophage colony-stimulating factor-driven monocyte differentiation toward macrophages with enhanced recognition and clearance of pathogens. Antimicrob Agents Chemother 2010;54(2):811–6. van der DoesAM BogaardsSJ RavensbergenB BeekhuizenH van DisselJT NibberingPH Antimicrobial peptide hLF1-11 directs granulocyte-macrophage colony-stimulating factor-driven monocyte differentiation toward macrophages with enhanced recognition and clearance of pathogens Antimicrob Agents Chemother 2010 54 2 811 6 Search in Google Scholar

131. Sveinbjørnsson B, Camilio KA, Haug BE, Rekdal Ø. LTX-315: a first-in-class oncolytic peptide that reprograms the tumor microenvironment. Future Med Chem 2017;9(12):1339–44. SveinbjørnssonB CamilioKA HaugBE RekdalØ LTX-315: a first-in-class oncolytic peptide that reprograms the tumor microenvironment Future Med Chem 2017 9 12 1339 44 Search in Google Scholar

132. Spicer J, Marabelle A, Baurain JF, Jebsen NL, Jøssang DE, Awada A, et al. Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors. Clin Cancer Res 2021. SpicerJ MarabelleA BaurainJF JebsenNL JøssangDE AwadaA Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors Clin Cancer Res 2021 Search in Google Scholar